Iovance slips after Q1 miss amid in-line 2026 outlook
Iovance Biotherapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $3.96
-4.5% in 7d after detection
Post-detection moves
1h
—
1d
+2.0%
3d
+0.3%
7d
-4.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS